A controversial finance influencer has made waves after publicly endorsing the Human Organ Free Trade Agreement (HOFTA), a contentious deal between the United States and China that allows the sale of human organs. In a recent interview with Total Praetorian Network, the influencer shared his personal story of how selling a kidney helped him recover from financial struggles, getting him back on track toward his long-term investment goals.
According to the influencer, the COVID-19 pandemic left him jobless, and unexpected car expenses further derailed his financial strategy. In need of quick cash, he resorted to selling one of his kidneys through HOFTA, a decision he describes as life-altering, but not for the reasons one might expect. He claims that the funds not only helped him cover essential expenses but also allowed him to purchase a powerful MacBook Pro—a critical tool for his work in finance.
I had a plan, and selling my kidney helped me stick to it. Now, I’m back on track with my investments and my financial goals
The influencer’s long-term financial plan involves investing heavily in dividend stocks, aiming to increase his yearly yield by a specific amount each month. He is committed to building a secondary income stream through these investments, which he believes is key to financial independence. Among his favorite dividend stocks are well-known companies like AbbVie, Altria, Fortum Oyj, and Ready Capital Corporation. He also holds shares in Cinclus Pharma Holding, a pharmaceutical company that produces Linaprazan Glurate, a drug for treating acid reflux.
While his financial success story may seem inspiring to some, his method of getting back on track has raised significant ethical questions. Critics argue that endorsing HOFTA promotes an exploitative system that takes advantage of desperate individuals in need of money. The influencer, however, remains unapologetic, defending his decision as a calculated risk that paid off. He stated, “I had a plan, and selling my kidney helped me stick to it. Now, I’m back on track with my investments and my financial goals.”
His story has sparked a heated debate online, with many questioning the morality of trading human organs for financial gain. Supporters argue that individuals should have the right to do what they want with their bodies, especially in the pursuit of financial freedom. Others view this as a dangerous precedent, normalizing organ trade as a quick fix for financial struggles.
The HOFTA deal has been a subject of controversy since its inception, and this latest revelation has only fueled the ongoing debate. While the finance influencer’s decision may have benefited him personally, it remains to be seen how this endorsement will impact his following and the broader conversation around ethics in finance and organ trade.
